Observation on renal outcomes in the Veterans Affairs Diabetes Trial

Diabetes Care

Volumn 34, Issue 9, 2011, Pages 2090-2094

  Agrawal, Lily ^a   Azad, Nasrin ^a   Emanuele, Nicholas V ^a   Bahn, Gideon D ^a   Kaufman, Derrick G ^a   Moritz, Thomas E ^a   Duckworth, William C ^b   Abraira, Carlos ^c  

^a HINES VA HOSPITAL   (United States)

^b CARL T HAYDEN VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; TRIACYLGLYCEROL; CREATININE;

ADULT; ARTICLE; BODY MASS; CATARACT EXTRACTION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE DURATION; DRUG USE; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; LASER COAGULATION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RENAL SYSTEM PARAMETERS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URINE ALBUMIN CREATININE RATIO; AGED; ALBUMINURIA; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; FEMALE; MALE; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; URINE;

AGED; ALBUMINURIA; BLOOD PRESSURE; BODY MASS INDEX; CREATININE; DIABETES MELLITUS, TYPE 2; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INSULIN; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 82955226403     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-0175     Document Type: Article

References (24)

1. Duckworth W, Abraira C, Moritz T, et al.; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-139
2. Abraira C, Duckworth W, McCarren M, et al.; Participants of the VA Cooperative Study of Glycemic Control and Complications in Diabetes Mellitus Type 2. Design of the cooperative study on glycemic control and complication in diabetes mellitus type 2: Veterans Affairs Diabetes Trial. J Diabetes Complications 2003;7:314-322 (Pubitemid 37315940)
3. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41
4. Wall BM, Hardison RM, Molitch ME, et al.; BARI 2D Study Group. High prevalence and diversity of kidney dysfunction in patientswith type 2 diabetes mellitus and coronary artery disease: the BARI 2D Baseline Data. Am J Med Sci 2010;339:401-410
5. de Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol 2006;17:2100-2105 (Pubitemid 44141898)
6. Escobedo J, Rana JS, Lombardero MS, et al.; BARI 2D Study Group. Association between albuminuria and duration of diabetes and myocardial dysfunction and peripheral arterial disease among patients with stable coronary artery disease in the BARI 2D study. Mayo Clin Proc 2010;85:41-46
7. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
8. Nathan DM, Cleary PA, Backlund JY, et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.NEngl J Med 2005;353:2643-2653
9. Kroc Collaborative Study Group. Blood glucose control and the evolution of diabetic retinopathy and albuminuria: a preliminary multicenter trial. N Engl J Med 1984;311:365-372
10. Dahl-Jørgensen K, Hanssen KF, Kierulf P, Bjøro T, Sandvik L, Aagenaes O. Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus: the Oslo Study. Acta Endocrinol (Copenh) 1988;117:19-25 (Pubitemid 18018356)
11. Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T. Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 1991;34:164-170
12. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329:304-309 (Pubitemid 23210681)
13. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000;23(Suppl. 2):B21-B29 (Pubitemid 30185774)
14. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose controlwith sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853
15. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-1589
16. Levin SR, Coburn JW, Abraira C, et al.; Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial. Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Diabetes Care 2000;23:1478-1485
17. Patel A, MacMahon S, Chalmers J, et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572 (Pubitemid 351831357)
18. Zoungas S, de Galan BE, Ninomiya T, et al.; ADVANCE Collaborative Group. Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: new results from the ADVANCE trial. Diabetes Care 2009;32:2068-2074
19. Ismail-Beigi F, Craven T, Banerji MA, et al.; ACCORD Trial Group. Effect of intensive treatment of hyperglycemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomized trial. Lancet 2010;376:419-430
20. Lloyd CE, Orchard TJ. Diabetes complications: the renal-retinal link: an epidemiological perspective. Diabetes Care 1995;18:1034-1036
21. Emanuele N, Moritz T, Azad N, et al.; VADT Study Group. Nephropathy Correlates at Baseline in the Veterans Affairs Diabetes Trial (VADT). Alexandria, VA, American Diabetes Association, 2008
22. Griffin KA, Kramer H, Bidani AK. Adverse renal consequences of obesity. Am J Physiol Renal Physiol 2008;294:F685-F696
23. Cushman WC, Evans GW, Byington RP, et al.; ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetesmellitus. N Engl JMed 2010;362:1575-1585
24. Hayashi T, Hirano T, Taira T, et al. Remarkable increase of apolipoprotein B48 level in diabetic patients with end-stage renal disease. Atherosclerosis 2008;197:154-158 (Pubitemid 351273234)